Pasithea Therapeutics
KTTA • NASDAQ • Stock Fundamentals
Pasithea Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Tiago Reis Marques, with a market cap of $20.3M.
Market Cap$20.3M
Employees8.0
CEOTiago Reis Marques
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 15, 2026 · 0 months 30 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
Pasithea Therapeutics FAQ
Common questions about Pasithea Therapeutics
Pasithea Therapeutics (KTTA) has a market capitalization of $20.3M and trades on NASDAQ.
Pasithea Therapeutics has approximately 8 employees.